| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
6,614.2930 | 11,374.9960 | 15,864.7730 | 19,433.9450 | 14,151.5160 |
| Cost of Revenue
|
-4,146.9190 | -6,253.4550 | -6,952.5600 | -10,921.7530 | -7,794.8520 |
|
Gross Profit
|
2,467.3740 | 5,121.5410 | 8,912.2130 | 8,512.1920 | 6,356.6640 |
| Selling, General and Administrative Expenses
|
-12,196.5100 | -11,304.6810 | -9,001.0290 | -13,408.0660 | -8,899.6020 |
|
Research and Development Expenses
|
-0.0730 | -8.0850 | -252.4510 | -514.4110 | -411.5240 |
|
Operating Income/Expenses
|
-12,196.5830 | -11,312.7660 | -9,253.4800 | -13,922.4770 | -9,311.1260 |
|
Total Operating Profit/Loss
|
-9,729.2090 | -6,191.2250 | -341.2670 | -5,410.2850 | -2,954.4620 |
| Total Net Finance Income/Expense
|
303.8650 | 343.1280 | 243.0080 | 237.0540 | 142.0140 |
| Irregular Income/Expenses
|
0 | 0 | 0 | -7,873.5130 | 0 |
|
Other Income/Expense, Non-Operating
|
-1,103.1710 | 79.4120 | 160.0150 | 1,069.7450 | 262.4420 |
|
Non-Operating Income/Expenses, Total
|
-799.3060 | 422.5400 | 403.0230 | -6,566.7140 | 404.4560 |
|
Pretax Income
|
-10,528.5150 | -5,768.6850 | 61.7560 | -11,976.9990 | -2,550.0060 |
|
Provision for Income Tax
|
130.7100 | -46.1820 | -335.1690 | 669.7600 | -272.3130 |
|
Net Income from Continuing Operations
|
-10,397.8050 | -5,814.8670 | -273.4130 | -11,307.2390 | -2,822.3190 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-10,397.8050 | -5,814.8670 | -273.4130 | -11,307.2390 | -2,822.3190 |
|
Non-Controlling/Minority Interests
|
-244.4370 | -495.2860 | -369.8160 | -28.6720 | -118.5720 |
|
Net Income after Non-Controlling/Minority Interests
|
-10,642.2420 | -6,310.1530 | -643.2290 | -11,335.9110 | -2,940.8910 |
|
Net Income Available to Common Stockholders
|
-10,642.2420 | -6,310.1530 | -643.2290 | -11,335.9110 | -2,940.8910 |
|
Diluted Net Income Available to Common Stockholders
|
-10,642.2420 | -6,310.1530 | -643.2290 | -11,335.9110 | -2,940.8910 |
| Basic EPS
|
-335.71 | -344.10 | -184.14 | -6.48k | -1.68k |
| Diluted EPS
|
-335.71 | -344.10 | -184.14 | -6.48k | -1.68k |
|
Basic Weighted Average Shares Outstanding
|
18.3780 | 18.3780 | 3.4980 | 1.7500 | 1.7470 |
|
Diluted Weighted Average Shares Outstanding
|
18.3780 | 18.3780 | 3.4980 | 1.7500 | 1.7470 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-10,832.3800 | -6,111.8130 | -181.2520 | -12,214.0530 | -2,692.0200 |
|
EBITDA
|
-10,521.1900 | -5,790.1460 | 247.1030 | -11,290.4390 | -1,961.7090 |
|
Normalized EBITDA
|
-3,983.3450 | -2,061.3170 | 243.9350 | -4,017.3950 | -1,591.9700 |
|
Normalized Income
|
-3,941.1273 | -2,086.0380 | -276.5810 | -4,126.7195 | -2,452.5800 |
|
Total Unusual Items
|
6,537.8450 | 3,728.8290 | -3.1680 | 7,273.0440 | 369.7390 |
|
Total Unusual Items Excluding Goodwill
|
6,537.8450 | 3,728.8290 | -3.1680 | 1,655.1790 | 369.7390 |
12/31/2022 - 2/25/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade